authors
- McKenzie, M
- Chi, K
- Neville, Alan
- Ellard, S
- Baerg, B
- Ruether, D
- Winquist, E
- Segal, R
- Attwell, A
- Lukka, Himu
34 Phase 2 study of neoadjuvant docetaxel and androgen suppression (AS) Plus Radiation Therapy (RT) for high risk localized prostate cancer (HRLCaP)
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- September 2006
has subject area
- 0299 Other Physical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Radiotherapy and Oncology Journal